Fri, June 1, 2012
Thu, May 31, 2012
Wed, May 30, 2012
Tue, May 29, 2012
Mon, May 28, 2012
Sun, May 27, 2012
Sat, May 26, 2012
Fri, May 25, 2012
Thu, May 24, 2012
Wed, May 23, 2012
[ Wed, May 23rd 2012 ]: Market Wire
Moody's Upgrades Mylan
Tue, May 22, 2012
Mon, May 21, 2012
Sun, May 20, 2012
Sat, May 19, 2012
Fri, May 18, 2012

Janssen and Johnson amp;; Johnson to Provide Webcast Presentation of ZYTIGA (abiraterone acetate)


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. -presentation-of-zytiga-abiraterone-acetate.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

Janssen and Johnson & Johnson to Provide Webcast Presentation of ZYTIGA... -- NEW BRUNSWICK, N.J., May 25, 2012 /PRNewswire/ --

Janssen and Johnson & Johnson to Provide Webcast Presentation of ZYTIGA (abiraterone acetate)

[ ]

Phase 3 Clinical Data Presented at the American Society of Clinical Oncology Annual Meeting

NEW BRUNSWICK, N.J., May 25, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: [ JNJ ]) will provide a pre-recorded webcast for investors and other interested parties on Saturday, June 2 at approximately 10:00 a.m., Eastern Time, to coincide with the American Society of Clinical Oncology's (ASCO) Annual Meeting in Chicago, Ill. 

Results from pre-specified interim analyses of COU-AA-302, a randomized, phase 3 study of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer, will be shown for the first time at ASCO.

The pre-recorded webcast with management from the Company's Janssen pharmaceutical subsidiaries, will provide an update on the results of the COU-AA-302 study and an update on the initial launch of ZYTIGA® (abiraterone acetate).

The webcast/podcast and replay can be accessed by visiting the Johnson & Johnson website at [ www.investor.jnj.com ] and clicking on "Webcasts/Presentations."

SOURCE Johnson & Johnson

[ Back to top ]

RELATED LINKS
[ http://www.jnj.com ]


Publication Contributing Sources